Baxter International (NYSE:BAX – Get Free Report) and LogicMark (OTCMKTS:LGMKD – Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.
Profitability
This table compares Baxter International and LogicMark’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Baxter International | -9.27% | 16.57% | 5.24% |
| LogicMark | -90.21% | -57.08% | -44.90% |
Insider & Institutional Ownership
90.2% of Baxter International shares are owned by institutional investors. Comparatively, 7.9% of LogicMark shares are owned by institutional investors. 0.2% of Baxter International shares are owned by company insiders. Comparatively, 2.2% of LogicMark shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Earnings and Valuation
This table compares Baxter International and LogicMark”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Baxter International | $11.24 billion | 1.16 | -$957.00 million | ($2.07) | -12.23 |
| LogicMark | $9.90 million | 0.12 | -$9.00 million | ($94.52) | -0.01 |
LogicMark has lower revenue, but higher earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than LogicMark, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of recent ratings and target prices for Baxter International and LogicMark, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Baxter International | 3 | 10 | 1 | 0 | 1.86 |
| LogicMark | 0 | 1 | 0 | 0 | 2.00 |
Baxter International presently has a consensus target price of $21.73, suggesting a potential downside of 14.19%. Given Baxter International’s higher probable upside, equities research analysts clearly believe Baxter International is more favorable than LogicMark.
Risk and Volatility
Baxter International has a beta of 0.65, meaning that its stock price is 35% less volatile than the S&P 500. Comparatively, LogicMark has a beta of 1.67, meaning that its stock price is 67% more volatile than the S&P 500.
Summary
Baxter International beats LogicMark on 9 of the 14 factors compared between the two stocks.
About Baxter International
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company’s products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors’ offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
About LogicMark
LogicMark, Inc. provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The company’s devices provide people with the ability to receive care at home and age independently and to check, manage, and monitor a loved one’s health and safety remotely. It also manufactures and distributes non-monitored and monitored personal emergency response systems, which are offered through the United States Veterans Health Administration (VHA), direct-to-consumers, healthcare durable medical equipment dealers and distributors, monitored security dealers and distributors, and its ecommerce website logicmark.com and Amazon.com. The company was formerly known as Nxt-ID, Inc. and changed its name to LogicMark, Inc. in March 2022. LogicMark, Inc. was founded in 2006 and is based in Louisville, Kentucky.
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.
